Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
0.650
-0.010 (-1.57%)
At close: Mar 28, 2024, 4:00 PM
0.639
-0.011 (-1.69%)
After-hours: Mar 28, 2024, 7:43 PM EDT

Cartesian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-219.7135.38-25.69-68.88-55.35-65.34-65.32-40.78-32.51-16.37
Depreciation & Amortization
2.62.622.371.862.030.980.750.81.040.86
Share-Based Compensation
22.5211.197.725.425.165.714.082.051.131.22
Other Operating Activities
143.43-80.83-44.7996.47-3.27-0.518.4613.60.54-1.89
Operating Cash Flow
-51.16-31.63-60.3834.88-51.44-59.16-52.03-19.76-22.46-12.69
Capital Expenditures
-0.21-1.2-1.09-0.740.08-0.79-0.73-0.58-1.16-0.23
Acquisitions
6.56000000000
Change in Investments
28.25-13.8-16.0600.1526.06-1.37-21.52-3.520
Investing Cash Flow
34.61-15-17.14-0.740.2325.27-2.1-22.1-4.68-0.23
Share Issuance / Repurchase
0.2339.3352.913.73107.840.75871.760.110.14
Debt Issued / Paid
-27.46-0.1105.42-2.808.02011.434.49
Other Financing Activities
14.08---4.72----4.132.3720.14
Financing Cash Flow
-13.1539.2252.914.43105.040.766.0267.6643.9124.77
Exchange Rate Effect
-0.050.02-0-0.060.03-0.150.080.46-1.02-3.32
Net Cash Flow
-29.75-7.4-24.6348.5153.87-33.3511.9826.2715.758.54
Free Cash Flow
-51.37-32.83-61.4734.14-51.36-59.95-52.76-20.34-23.63-12.91
Free Cash Flow Margin
-197.53%-29.64%-72.25%205.70%-769.21%-6638.54%-25485.51%-251.65%-393.05%-424.77%
Free Cash Flow Per Share
-0.33-0.23-0.540.34-1.13-2.68-2.58-1.94-10.99-6.18
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).